Human dopamine beta-hydroxylase (DBH) regulatory polymorphism that influences enzymatic activity, autonomic function, and blood pressure

Journal of Hypertension

Volumn 28, Issue 1, 2010, Pages 76-86

  Chen, Yuqing ^a,f   Wen, Gen ^a   Rao, Fangwen ^a   Zhang, Kuixing ^a   Wang, Lei ^a   Rodriguez Flores, Juan L ^a   Sanchez, Amber P ^a   Mahata, Manjula ^a   Taupenot, Laurent ^a   Sun, Ping ^a   Mahata, Sushil K ^a   Tayo, Bamidele ^e   Schork, Nicholas J ^b   Ziegler, Michael G ^a   Hamilton, Bruce A ^a   O'Connor, Daniel T ^a,b,c,d  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b Department of Pharmacology ^*

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^e LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^f PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Dopamine beta hydroxylase; Hypertension; Polymorphism

Indexed keywords

ADRENALIN; DOPAMINE BETA MONOOXYGENASE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD PRESSURE; CHROMAFFIN CELL; CHROMATIN; ENVIRONMENTAL STRESS; ENZYME ACTIVITY; ENZYME POLYMORPHISM; ENZYME REGULATION; ETHNICITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HYPERTENSION; IMMUNOPRECIPITATION; IN VIVO STUDY; MAJOR CLINICAL STUDY; MUTAGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION;

EID: 73849108040     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328332bc87     Document Type: Article

References (63)

1. Kim CH, Zabetian CP, Cubells JF, Cho S, Biaggioni I, Cohen BM, et al. Mutations in the dopamine beta-hydroxylase gene are associated with human norepinephrine deficiency. Am J Med Genet 2002; 108:140-147.
2. De Potter WP, De Schaepdryver AF, Smith AD. Release of chromogranin A and dopamine-beta-hydroxylase from adrenergic nerves during nerve stimulation. Acta Physiol Scand Suppl 1970; 357:8.
3. Weinshilboum RM, Thoa NB, Johnson DG, Kopin IJ, Axelrod J. Proportional release of norepinephrine and dopamine-beta-hydroxylase from sympathetic nerves. Science 1971; 174:1349-1351.
4. O'Connor DT, Cervenka JH, Stone RA, Levine GL, Parmer RJ, Franco-Bourland RE, et al. Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency. Clin Sci (Lond) 1994; 86:149-158.
5. Weinshilboum RM, Raymond FA, Elveback LR, Weidman WH. Serum dopamine-beta-hydroxylase activity: sibling-sibling correlation. Science 1973; 181:943-945.
6. Weinshilboum RM, Schorott HG, Raymond FA, Weidman WH, Elveback LR. Inheritance of very low serum dopamine-beta-hydroxylase activity. Am J Hum Genet 1975; 27:573-585.
7. Oxenstierna G, Edman G, Iselius L, Oreland L, Ross SB, Sedvall G. Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals: a genetic study. J Psychiatr Res 1986; 20:19-29.
8. Craig SP, Buckle VJ, Lamouroux A, Mallet J, Craig IW. Localization of the human dopamine beta hydroxylase (DBH) gene to chromosome 9q34. Cytogenet Cell Genet 1988; 48:48-50.
9. Perry SE, Summar ML, Phillips JA 3rd, Robertson D. Linkage analysis of the human dopamine beta-hydroxylase gene. Genomics 1991; 10:493-495.
10. Cubells JF, van Kammen DP, Kelley ME, Anderson GM,O'Connor DT, Price LH, et al. Dopamine beta-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation. Hum Genet 1998; 102:533-540.
11. Wei J, Ramchand CN, Hemmings GP. Possible control of dopamine beta-hydroxylase via a codominant mechanism associated with the polymorphic (GT)n repeat at its gene locus in healthy individuals. Hum Genet 1997; 99:52-55.
12. Zabetian CP, Anderson GM, Buxbaum SG, Elston RC, Ichinose H,Nagatsu T, et al. A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet 2001; 68:515-522.
13. Esler M, Ferrier C, Lambert G, Eisenhofer G, Cox H, Jennings G. Biochemical evidence of sympathetic hyperactivity in human hypertension. Hypertension 1991; 17:III29-III35.
14. Ferrier C, Cox H, Esler M. Elevated total body noradrenaline spillover in normotensive members of hypertensive families. Clin Sci (Lond) 1993; 84:225-230.
15. Robertson D, Haile V, Perry SE, Robertson RM, Phillips JA 3rd, Biaggioni I. Dopamine beta-hydroxylase deficiency. A genetic disorder of cardiovascular regulation. Hypertension 1991; 18:1-8.
16. Swoap SJ, Weinshenker D, Palmiter RD, Garber G. Dbh(\-/\-) mice are hypotensive, have altered circadian rhythms, and have abnormal responses to dieting and stress. Am J Physiol Regul Integr Comp Physiol 2004; 286: R108-R113.
17. Ohlstein EH, Kruse LI, Ezekiel M, Sherman SS, Erickson R, DeWolf WE Jr, Berkowitz BA. Cardiovascular effects of a new potent dopamine beta-hydroxylase inhibitor in spontaneously hypertensive rats. J Pharmacol Exp Ther 1987; 241:554-559.
18. Ross ST, Kruse LI, Ohlstein EH, Erickson RW, Ezekiel M, Flaim KE, et al. Inhibitors of dopamine beta-hydroxylase. 3. Some 1-(pyridylmethyl)imidazole-2- thiones. J Med Chem 1987; 30:1309-1313.
19. Greenwood TA, Rao F, Stridsberg M, Mahapatra NR, Mahata M, Lillie EO, et al. Pleiotropic effects of novel trans-acting loci influencing human sympathochromaffin secretion. Physiol Genomics 2006; 25:470-479.
20. Seasholtz TM, Wessel J, Rao F, Rana BK, Khandrika S, Kennedy BP, Lillie EO, et al. Rho kinase polymorphism influences blood pressure and systemic vascular resistance in human twins: role of heredity. Hypertension 2006; 47:937-947.
21. Wessel J, Moratorio G, Rao F, Rana BK, Khandrika S, Kennedy BP, et al. C-reactive protein, an 'intermediate phenotype' for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/beta- adrenergic pathway loci. J Hypertens 2007; 25:329-343.
22. Zhang L, Rao F, Wessel J, Kennedy BP, Rana BK, Taupenot L, et al. Functional allelic heterogeneity and pleiotropy of a repeat polymorphism in tyrosine hydroxylase: prediction of catecholamines and response to stress in twins. Physiol Genomics 2004; 19:277-291.
23. Kennedy BP, Rao F, Botiglieri T, Sharma S, Lillie EO, Ziegler MG, O'Connor DT. Contributions of the sympathetic nervous system, glutathione, body mass and gender to blood pressure increase with normal aging: influence of heredity. J Hum Hypertens 2005; 19:951-969.
24. Rao F, Wen G, Gayen JR, Das M, Vaingankar SM, Rana BK, et al. Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension. Circulation 2007; 115:2271-2281.
25. Cooper R, Rotimi C, Ataman S, McGee D,Osotimehin B, Kadiri S, et al. The prevalence of hypertension in seven populations of west African origin. Am J Public Health 1997; 87:160-168.
26. Cui JS, Hopper JL, Harrap SB. Antihypertensive treatments obscure familial contributions to blood pressure variation. Hypertension 2003; 41:207-210.
27. Wu J, Kraja AT, Oberman A, Lewis CE, Ellison RC, Arnett DK, et al. A summary of the effects of antihypertensive medications on measured blood pressure. Am J Hypertens 2005; 18:935-942.
28. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132:365-386.
29. Concepcion D, Seburn KL, Wen G, Frankel WN, Hamilton BA. Mutation rate and predicted phenotypic target sizes in ethylnitrosourea-treated mice. Genetics 2004; 168:953-959.
30. Wen G, Mahata SK, Cadman P, Mahata M, Ghosh S, Mahapatra NR, et al. Both rare and common polymorphisms contribute functional variation at CHGA, a regulator of catecholamine physiology. Am J Hum Genet 2004; 74:197-207.
31. Ewing B, Green P. Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res 1998; 8:186-194. (Pubitemid 28177230)
32. Gordon D, Abajian C, Green P. Consed: a graphical tool for sequence finishing. Genome Res 1998; 8:195-202.
33. Nickerson DA, Tobe VO, Taylor SL. PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res 1997; 25:2745-2751.
34. O'Connor DT, Levine GL, Frigon RP. Homologous radio-immunoassay of human plasma dopamine-beta-hydroxylase: analysis of homospecific activity, circulating plasma pool and intergroup differences based on race, blood pressure and cardiac function. J Hypertens 1983; 1:227-233.
35. Kennedy B, Ziegler MG. A more sensitive and specific radioenzymatic assay for catecholamines. Life Sci 1990; 47:2143-2153.
36. Wen G, Wessel J, Zhou W, Ehret GB, Rao F, Stridsberg M, et al. An ancestral variant of secretogranin II confers regulation by PHOX2 transcription factors and association with hypertension. Hum Mol Genet 2007; 16:1752-1764.
37. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68:978-989.
38. Eskin E, Sharan R, Halperin E. A note on phasing long genomic regions using local haplotype predictions. J Bioinform Comput Biol 2006; 4:639-647.
39. Abecasis GR, Cookson WO. GOLD: graphical overview of linkage disequilibrium. Bioinformatics 2000; 16:182-183.
40. Barrett J, Fry B, Maller J, Daly M. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21:263-265.
41. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004; 74:765-769.
42. Smith TF, Waterman MS. Identification of common molecular subsequences. J Mol Biol 1981; 147:195-197.
43. Vlieghe D, Sandelin A, DeBleser PJ,et al.A new generation ofJASPAR, the open-access repository for transcription factor binding site profiles. Nucleic Acids Res 2006; 34:D95-D97.
44. Wingender E, Dietze P, Karas H, Knuppel R. TRANSFAC: a database on transcription factors and their DNA binding sites. Nucleic Acids Res 1996; 24:238-241.
45. Sandelin A, Wasserman WW, Lenhard B. ConSite: web-based prediction of regulatory elements using cross-species comparison. Nucleic Acids Res 2004; 32:W249-252.
46. Wasserman WW, Sandelin A. Applied bioinformatics for the identification of regulatory elements. Nat Rev Genet 2004; 5:276-287.
47. Zhang K, Jin L. HaploBlockFinder: haplotype block analyses. Bioinformatics 2003; 19:1300-1301.
48. O'Connor D, Frigon R, Stone R. Human pheochromocytoma dopamine-beta-hydroxylase: purification and molecular parameters of the tetramer. Mol Pharmacol 1979; 16:529-538.
49. Wu HJ, Parmer RJ, Koop AH, Rozansky DJ, O'Connor DT. Molecular cloning, structure, and expression of dopamine-beta-hydroxylase from bovine adrenal medulla. J Neurochem 1990; 55:97-105.
50. Voors AW, Berenson GS, Dalferes ER, Webber LS, Shuler SE. Racial differences in blood pressure control. Science 1979; 204:1091-1094.
51. Schork NJ, Fallin D, Thiel B, Xu X, Broeckel U, Jacob HJ, Cohen D. The future of genetic case-control studies. Adv Genet 2001; 42:191-212.
52. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994; 265:2037-2048.
53. Lillie EO, O'Connor DT. Early phenotypic changes in hypertension: a role for the autonomic nervous system and heredity. Hypertension 2006; 47:331-333.
54. Kasagi F, Akahoshi M, Shimaoka K. Relation between cold pressor test and development of hypertension based on 28-year follow-up. Hypertension 1995; 25:71-76.
55. Menkes MS, Matthews KA, Krantz DS, Lundberg U, Mead LA, Qaqish B, et al. Cardiovascular reactivity to the cold pressor test as a predictor of hypertension. Hypertension 1989; 14:524-530.
56. Schneider GM, Jacobs DW, Gevirtz RN, O'Connor DT. Cardiovascular haemodynamic response to repeated mental stress in normotensive subjects at genetic risk of hypertension: evidence of enhanced reactivity, blunted adaptation, and delayed recovery. J Hum Hypertens 2003; 17:829-840.
57. Snieder H, Harshfield GA, Barbeau P, Pollock DM, Pollock JS, Treiber FA. Dissecting the genetic architecture of the cardiovascular and renal stress response. Biol Psychol 2002; 61:73-95.
58. Treiber FA, Kamarck T, Schneiderman N, Sheffield D, Kapuku G, Taylor T. Cardiovascular reactivity and development of preclinical and clinical disease states. Psychosom Med 2003; 65:46-62.
59. O'Connor DT, Insel PA, Ziegler MG, Hook VY, Smith DW, Hamilton BA, et al. Heredity and the autonomic nervous system in human hypertension. Curr Hypertens Rep 2000; 2:16-22.
60. O'Connor DT, Kailasam MT, Kennedy BP, Ziegler MG, Yanaihara N,Parmer RJ. Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension. J Hypertens 2002; 20:1335-1345.
61. Reich DE, Lander ES. On the allelic spectrum of human disease. Trends Genet 2001; 17:502-510.
62. Carrasquillo MM, McCallion AS, Puffenberger EG, Kashuk CS, Nouri N, Chakravarti A. Genome-wide association study and mouse model identify interaction between RET and EDNRB pathways in Hirschsprung disease. Nat Genet 2002; 32:237-244.
63. Ma DQ, Whitehead PL, Menold MM, Martin ER, Ashley-Koch AE, Mei H, et al. Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism. Am J Hum Genet 2005; 77:377-388.